Taro Pharmaceutical Industries shares owned by Credit Suisse
Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Taro Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Taro Pharmaceutical Industries held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taro Pharmaceutical Industries by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $549k | 13k | 41.78 |
| 2023-09-30 | $439k | 12k | 37.71 |
| 2023-06-30 | $460k | 12k | 37.93 |
| 2023-03-31 | $374k | 15k | 24.32 |
| 2022-12-31 | $447k | 15k | 29.04 |
| 2022-09-30 | $449k | 15k | 30.61 |
| 2022-06-30 | $495k | 14k | 35.71 |
| 2022-03-31 | $629k | 15k | 42.52 |
| 2021-12-31 | $698k | 14k | 49.32 |
| 2021-09-30 | $939k | 15k | 62.66 |
| 2021-06-30 | $1.1M | 15k | 73.11 |
| 2021-03-31 | $1.4M | 19k | 73.78 |
| 2020-12-31 | $1.4M | 19k | 73.52 |
| 2020-03-31 | $269k | 4.8k | 55.56 |
| 2019-06-30 | $263k | 2.4k | 111.11 |
| 2019-03-31 | $217k | 2.0k | 111.11 |
| 2018-09-30 | $387k | 3.9k | 98.24 |
| 2018-06-30 | $716k | 6.2k | 114.79 |
| 2017-12-31 | $1.1M | 9.7k | 111.11 |
| 2017-09-30 | $1.7M | 16k | 110.24 |
| 2017-06-30 | $1.7M | 15k | 111.11 |
| 2017-03-31 | $2.2M | 19k | 116.67 |
| 2016-12-31 | $1.9M | 18k | 105.56 |
| 2016-09-30 | $3.6M | 32k | 110.51 |
| 2016-06-30 | $2.4M | 17k | 145.59 |
| 2016-03-31 | $2.2M | 15k | 144.65 |
| 2015-12-31 | $2.7M | 17k | 156.25 |
| 2015-09-30 | $1.2M | 8.6k | 142.88 |
| 2015-06-30 | $2.7M | 19k | 143.63 |
| 2015-03-31 | $7.1M | 50k | 141.09 |
| 2014-12-31 | $4.7M | 32k | 148.21 |
| 2014-09-30 | $7.4M | 48k | 153.75 |
| 2014-06-30 | $761k | 5.4k | 140.31 |
| 2014-03-31 | $545k | 4.9k | 111.09 |
| 2013-12-31 | $702k | 7.1k | 98.86 |
| 2013-09-30 | $426k | 5.6k | 75.95 |
Top funds holding Taro Pharmaceutical Industries
View all funds holding Taro Pharmaceutical Industries